返回管委会首页
繁體 |English |日语 |无障碍 |关怀版
Home page > Top stories

SIP’s biological pharmaceutical and product manufacturing cluster designated a national-level innovative industrial cluster

Date:2023-02-17 09:34:00|Source:|Font Size: AAA

The Torch High Technology Industry Development Center at the Ministry of Science and Technology of China recently released the 2022 list of innovative industrial clusters. SIP’s biological pharmaceutical and product manufacturing cluster is on the list.

SIP is now home to more than 2,200 biomedicine enterprises with a total annual output value of RMB 130 billion. These enterprises, attracting social capital investment of about RMB 20 billion each year, have received over 500 approvals in total for clinical trials of Class-I drug candidates and over 1,300 registration certificates for medical devices, and brought 22 new drugs into the market.

In the recent three years, SIP introduced more than 300 biomedicine projects each year, and the talent pool has been expanding, currently with more than 50,000 people engaged in innovation of biomedicine.

SIP authorities said they would enhance support for the biomedical industry to continuously improve the innovation ecosystem and the industry chain to create a world-class biomedicine cluster.

February 16, 2023

Copyright © www.sipac.gov.cn   |  Contact us